Turkish Journal of Biology
Volume 43

Number 3

Article 3

1-1-2019

Squalene attenuates the oxidative stress and activates AKT/
mTOR pathway against cisplatin-induced kidney damage in mice
AYŞE ARZU ŞAKUL
MEHMET OZANSOY
BİRSEN ELİBOL
ŞULE AYLA
MEHMET YALÇIN GÜNAL

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
ŞAKUL, AYŞE ARZU; OZANSOY, MEHMET; ELİBOL, BİRSEN; AYLA, ŞULE; GÜNAL, MEHMET YALÇIN;
YOZGAT, YASEMİN; BAŞAĞA, SELMA HÜVEYDA; ŞAHİN, KAZİM; KAZANCIOĞLU, RÜMEYZA; and KILIÇ,
ÜLKAN (2019) "Squalene attenuates the oxidative stress and activates AKT/mTOR pathway against
cisplatin-induced kidney damage in mice," Turkish Journal of Biology: Vol. 43: No. 3, Article 3.
https://doi.org/10.3906/biy-1902-77
Available at: https://journals.tubitak.gov.tr/biology/vol43/iss3/3

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Squalene attenuates the oxidative stress and activates AKT/mTOR pathway
against cisplatin-induced kidney damage in mice
Authors
AYŞE ARZU ŞAKUL, MEHMET OZANSOY, BİRSEN ELİBOL, ŞULE AYLA, MEHMET YALÇIN GÜNAL,
YASEMİN YOZGAT, SELMA HÜVEYDA BAŞAĞA, KAZİM ŞAHİN, RÜMEYZA KAZANCIOĞLU, and ÜLKAN
KILIÇ

This article is available in Turkish Journal of Biology: https://journals.tubitak.gov.tr/biology/vol43/iss3/3

Turkish Journal of Biology
http://journals.tubitak.gov.tr/biology/

Research Article

Turk J Biol
(2019) 43: 179-188
© TÜBİTAK
doi:10.3906/biy-1902-77

Squalene attenuates the oxidative stress and activates AKT/mTOR pathway against
cisplatin-induced kidney damage in mice
1

2

3

4

5

6

Arzu SAKUL , Mehmet OZANSOY , Birsen ELİBOL , Şule AYLA , Mehmet Yalçın GÜNAL , Yasemin YOZGAT ,
7
8
9,
10,
Hüveyda BAŞAĞA , Kazım ŞAHİN , Rümeyza KAZANCIOĞLU *, Ülkan KILIÇ *
1
Department of Medical Pharmacology, School of Medicine, İstanbul Medipol University, İstanbul, Turkey
2
Department of Physiology, School of Medicine, İstanbul Medipol University, İstanbul, Turkey
3
Department of Medical Biology, Faculty of Medicine, Bezmialem Vakıf University, İstanbul, Turkey
4
Department of Histology and Embryology, School of Medicine, İstanbul Medipol University, İstanbul, Turkey
5
Department of Physiology, Alanya Alaaddin Keykubat University School of Medicine, Antalya, Turkey
6
Regenerative and Restorative Medical Research Center (REMER), İstanbul Medipol University, İstanbul, Turkey
7
Biological Sciences and Bioengineering Program, Faculty of Engineering and Natural Sciences,
Sabancı University, İstanbul, Turkey
8
Department of Animal Nutrition, Faculty of Veterinary Medicine, Fırat University, Elazığ, Turkey
9
Department of Nephrology, Faculty of Medicine, Bezmialem Vakıf University, İstanbul, Turkey
10
Department of Medical Biology, Faculty of Medicine, University of Health Sciences, İstanbul, Turkey
Received: 26.02.2019

Accepted/Published Online: 20.05.2019

Final Version: 13.06.2019

Abstract: The clinical use of cisplatin, which is a first-line anticancer agent, is highly restricted due to its adverse effects on kidneys
that lead to nephrotoxicity. Therefore, some potential reno-protective substances have been used in combination with cisplatin to cope
with nephrotoxicity. Due to its high antitumor activity and oxygen-carrying capacity, we investigated the molecular effects of squalene
against cisplatin-induced oxidative stress and kidney damage in mice. Single dose of cisplatin (7 mg/kg) was given to male Balb/c mice.
Squalene (100 mg/kg/day) was administered orogastrically to mice for 10 days. Following sacrification, molecular alterations were
investigated as analysis of the levels of oxidative stress index (OSI), inflammatory cytokines and cell survival-related proteins in addition
to histopathological examinations in mice kidney tissue. The level OSI and Interferon-gamma (IFN-γ) decreased in the cisplatin and
squalene cotreated mice compared to cisplatin-treated mice. Squalene treatment also increased the activation of protein kinase B (AKT).
Furthermore, cisplatin-induced inactivation of mammalian target of rapamycin (mTOR) and histopathological damages were reversed
by squalene. It may be suggested that squalene ameliorated the cisplatin-induced histopathological damages in the kidney through
activation of AKT/mTOR signaling pathway by regulating the balance of the redox system due to its antioxidative effect.
Key words: AKT, cisplatin-induced nephrotoxicity, mice, mTOR, oxidative-stress, squalene

1. Introduction
Chemotherapeutic agents used in the treatment of various
types of cancer have side effects such as ototoxicity and
nephrotoxicity. The toxic effects of these antineoplastic
drugs can be ignored because of their potency of improving
an individual’s chances of survival by impairing mitosis of
fast-dividing cancer cells (Kilic et al., 2015a). In general, in
terms of their mechanism of action, the chemotherapeutic
agents fall into several categories including alkylating
agents, antimetabolites, mitotic inhibitors, antibiotics,
enzymes, hormones, and hormone antagonists. Cisplatin, a
platinum compound (cis diamminedichloridoplatinum(II)
(CDDP), is the first member of these chemotherapy drugs

which is used against various forms of solid cancers
(e.g., small cell lung cancer, squamous cell carcinoma of
the head and neck, bladder cancer, cervical cancer and
ovarian cancer), sarcomas, and lymphomas (Ho et al.,
2003; Li et al., 2017). The action mechanism of cisplatin
occurs by binding to DNA of fast proliferating cells and
causing the DNA strands to crosslink that triggers cell
death in a programmed manner (Wang and Lippard,
2005). However, due to its strong electrophilic nature,
cisplatin induces oxidative stress producing adverse side
effects such as nephrotoxicity (Arany and Safirstein, 2003;
Kilic et al., 2015a). The nephrotoxicity of platinum-class
chemotherapeutics can be ameliorated using some free
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radical scavenging agents (Shimeda et al., 2005; Kilic et
al., 2013). Therefore, variety of compounds obtained from
medicinal plants is used as chemopreventive antioxidant
agents. It has been documented that the activators of some
antioxidant proteins like nuclear factor erythroid 2-related
factor 2 (Nrf2), a redox-sensitive transcription factor, such
as polyphenols, sulfur-containing terpenoids, carotenoids,
and selenium induce the expression of cytoprotective
proteins in an antioxidant response elements-dependent
manner (Sies and Masumoto, 1997; Kilic et al., 2013).
Squalene (2,6,10,15,19,23-hexamethyl-6,6,10,14,18,20tetracosahexane), a natural 30-carbon organic compound,
may be one of these chemopreventive agents that shows
beneficial effects on health (Smith, 2000; Sotiroudis and
Kyrtopoulos, 2008) (Figure 1). It is a polyunsaturated
triterpene which is found in high concentrations in shark
liver, vegetable oils, and in the stomach oil of birds (Liu
et al., 1976; Vazquez et al., 2008). Previous animal studies
proposed that squalene have the antitumor activity and
the ability to reduce the cancer risk (Newmark, 1997;
Sotiroudis and Kyrtopoulos, 2008). The inhibitory effect
on cancer promotion and the selective cytoprotective
effect in the protection of normal cells against toxicity of
chemotherapeutics while showing no protective efficacy
for tumor cells made squalene possible as a primarily used
supportive therapy in a variety of cancers (Senthilkumar et
al., 2006a and 2006b). The inhibition of Ras farnesylation,
the modulation of carcinogen activation and antioxidative
activities are the proposed mechanisms for the
chemopreventive activity of squalene (Newmark, 1997;
Smith, 2000). Squalene attenuates oxidative DNA damage
in human cells by reducing the levels of reactive oxygen
species in vitro (Warleta et al., 2010). Oxygenation effect of
squalene on cells is thought to be effective because higher
cellular oxygen levels provide a more efficient metabolic
process and thus enhance cell energy metabolism. In
addition to its chemopreventive activity through its
antioxidant effect, much more research is clearly needed
to determine cytoprotective effect of squalene against
side effects of chemotherapeutics. Therefore, we aimed to

Figure 1. Chemical structure of squalene; a simple linear mode
of presentation and the cyclization of squalene (Adapted from
Newmark, 1999).
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investigate the molecular mechanism of renoprotection of
squalene in an animal model of cisplatin-induced kidney
damage.
2. Methods
2.1. Animal experiments
Balb/c mice that are more susceptible to disease models
(Foerster et al., 2017) (n = 7 for each group) weighing 25
g obtained from İstanbul Medipol University Research
Center (MEDITAM) were used in this study. Because of
the protective role of estrogen in the cisplatin-induced
kidney damage (Nematbakhsh et al., 2017; Pezeshki
et al., 2013), male mice were used in the present study
to obtain an effective cisplatin-induced nephrotoxicity
model. The animals were acclimatized for 1 week before
the study and were maintained under standard conditions
(12 h light/dark cycles, 22 °C, and 60% humidity) with ad
libitum food and water. All experimental procedures were
approved by the Ethics Review Committee for Ethics in
Animal Experiments of the İstanbul Medipol University
(14.01.2015/05) and guidelines for the Care and Use of
Laboratory animals were strictly followed.
The mice were divided into five groups; control
receiving saline (i.p.) (Cs), control receiving corn oil
(250 mg/kg body weight, daily orogastric gavage) (Cco),
cisplatin-treated (single dose, 7 mg/kg body weight., i.p.
dissolved in 0.9% saline) (Cis), squalene-treated (100 mg/
kg squalene (Das et al., 2008) dissolved in warm corn oil,
daily orogastric gavage) (Squa), cisplatin (single dose,
7 mg/kg b.w., i.p. dissolved in 0.9% saline) and squalene
(100 mg/kg squalene (dissolved in warm corn oil, daily
orogastric gavage) cotreated (Cis/Squa). After 10 days, the
mice were sacrificed under ketamine/xylazine anesthesia,
blood samples were taken and the kidneys were dissected
for histological and molecular analysis.
2.2. Oxidative stress analysis
Total antioxidant status (TAS) and total oxidant status
(TOS) of blood were measured colorimetrically using
RelAssay Diagnostics Kits (Gaziantep, Turkey) using
an automated measurement method by an automated
analyzer (Chromate Manager 4300, Palm City/USA). As
described in a previous study (Kilic et al., 2015b), the
measurement of TAS was performed by monitoring the
rates of the Fenton reaction and it was expressed as in
terms of mmol equiv/L Trolox (Rel Assay Diagnostics,
Gaziantep, Turkey). Similarly, the measurement of
TOS was performed by monitoring the intensity of the
colored complex produced by the reaction of ferric ions
with xylenol orange and it was expressed as in terms of
micromolar hydrogen peroxide (H2O2) equivalents per
liter (μmol H2O2 equiv/L). Using these TAS and TOS
values, oxidative stress index (OSI) was calculated for each
sample using the following formula (Shimeda et al., 2005):
OSI = (TOS) / (TAS) × 1000) × 100
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2.3. Analyses of proinflammatory/antiinflammatory
cytokines
Proinflammatory markers (interferon-gamma (IFNγ),
Interleukin (IL)17 and tumor necrosis factor-alpha
(TNF-α)) and antiinflammatory markers (IL6 and IL10)
from the kidney tissue homogenates were measured using
Magpix Luminex System (Austin, TX, USA). Briefly,
samples were incubated with primary antibodies for each
cytokine which were immobilized on magnetic beads
overnight at 4 °C. On the following day, the samples were
incubated with streptavidin-phycoerythrein solution in
dark at room temperature. They were then were measured
luminometrically and the data were evaluated using
XPONENT software.
2.4. Western blot analysis
The total protein extraction was performed from
homogenates of one of the kidney tissues of animals.
Equal amounts of protein which were determined using
Qubit Fluorometer 2.0 (Invitrogen, USA) were diluted
in sample buffer, denatured, and loaded onto 4%–12%
Bis-Tris polyacrylamide gels (Invitrogen). Proteins
were transferred onto polyvinylidene fluoride (PVDF)
membranes with iBlot® (Invitrogen) gel transfer system.
Membranes were dried, incubated in blocking solution
(5% milk powder in 0.1% Tween 20/0.1 M Tris-buffered
saline (TBST)), and immersed with primary antibodies
(anti-p-mTOR (mammalian target of rapamycin), antimTOR, anti-Akt (protein kinese B), anti-p-Akt, anti-GSK3β (glycogen synthase kinase-3), anti-Nrf2) (Santa Cruz,
CA, USA) in appropriate concentrations for incubation
overnight at 4°C. On the following day, the secondary
antibodies (horseradish peroxidase-linked goat antimouse
IgG (immunoglobulin G), Abcam, Cambridge, UK) were
used to incubate membrane for 1 h at room temperature.
All blots were performed at least three times and they
were developed by using Enhanced Chemiluminescence
-Advanced Western Blotting Detection Kit (Amersham,
UK). Proteins were visualized by Bio-Rad ChemiDoc XRS
System (Bio-Rad Laboratories Inc., USA) and analyzed
densitometrically using ImageJ software. The samples were
normalized using a monoclonal mouse antibody against to
β-actin (A5316; Sigma, USA).
2.5. Histological evaluation
From the sacrificed animals, the other kidney tissues were
taken and the entire tissue blocks were covered with cryoembedding media to store the frozen tissue block at –80°
C until ready for sectioning. The frozen tissue block was
cut on a cryotome into 5–7 µm sections for histological
examinations. The kidney sections were stained with
periodic acid Schiff (PAS) using conventional methods
for light microscopic examinations (Nikon Eclipse Ni
research microscope). As described in one of our studies
(Ayla et al., 2011), a semiquantitative score was developed
to evaluate the degree of the damage by examining

a minimum of 20 glomeruli (range 20 to 60) in each
specimen. The scores obtained by the two investigators
were averaged. Photographs of sections were taken at
different magnifications in a Nikon Eclipse Ni research
microscope, fitted with Nikon DS-Fi2 model digital
camera and used Nikon Sight D5 V3 software.
2.6. Data analysis and statistics
Statistical analysis was performed using SPSS 18.0 for
Windows. Significance was evaluated by one-way ANOVA.
The post hoc comparisons of simple effects were conducted
using Fisher’s Least Significant Difference (LSD) test. The
criterion of statistical significance was P ≤ 0.05. All values
are given as mean ± S.D.
3. Results
3.1. Oxidative stress markers
To measure the antioxidative effect of squalene, we
determined the TAS, TOS, and OSI levels for each group.
Figure 2 shows that oxidative stress (both OSI and TOS
levels) was found to be increased nearly 6-fold in the Cis
group relative to the Cs group (P < 0.05), whereas OSI
value decreased in the cisplatin and squalene co-treated
(Cis/Squa) group (P < 0.05) (Figure 2).
3.2. Proinflammatory and antiinflammatory markers
To investigate the effect of both cisplatin and squalene
on the inflammation, we measured the concentration of
proinflammatory and antiinflammatory markers in the
kidney tissues (Figure 3). According to one-way ANOVA,
there is a marginal difference between-groups in the level
of IFN-γ (F(4,23) = 2.478, P = 0.079). The post hoc LSD
test showed that the level of IFN-γ in the cisplatin and
squalene cotreated mice was significantly lower than both
the level of IFN-γ in the cisplatin-treated group (P = 0.038)
and the squalene-treated group (P = 0.009) (Figure 3).
However, in the other inflammatory markers, there was no
treatment effect among the studied groups (IL-6, F(4,23) =
0.902, P = 0.482; IL-10, F(4,23) = 1.607, P = 0.214; IL-17,
F(4,23) = 0.211, P = 0.929; and TNF-α, F(4,23) = 0.723, P
= 0.587).
3.3. Protein expression alterations
Protein homogenates isolated from kidneys were also
used to determine the changes in the levels of following
proteins: GSK-3β, Akt, p-Akt, mTOR, p-mTOR, and Nrf2 (Figure 4). The expression level of total GSK-3β was
significantly increased in cisplatin and squalene cotreated
mice and control mice receiving corn oil by gavage
relative to the control mice receiving saline (37.32% and
45.50%, respectively; P < 0.05, Figure 4a). In addition, the
expression level of total GSK-3β of cisplatin and squalene
cotreated mice was significantly increased compared to
that of the cisplatin-treated mice, by 62.75% (P < 0.05).
Western blots of the ratio of phospho-Akt to total AKT
were visualized in Figure 4b. According to the one-way
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Figure 2. Levels of TAS, TOS, and OSI in Cs (control-received saline), Cis (cisplatin-treated), Cis/Squa (cisplatin and squalene cotreated),
Squa (squalene-treated), and Cco (control receiving corn oil) groups in the blood serum. TOS and OSI levels decreased significantly
in Cis/Squa group relative to the Cis group. (*) indicates the comparison with the Cs group, (#) indicates the comparison with the Cis
group. The results are shown as mean ± standart error of mean (SEM). A.U., Arbitrary units.

Figure 3. The concentrations of selected inflammatory markers
(IFNγ, IL6, IL10, IL17, and TNF-α) in the kidney tissue
homogenates which were measured using Magpix Luminex
System in Cs (control-received saline), Cis (cisplatin-treated),
Cis/Squa (cisplatin and squalene cotreated), Squa (Squalenetreated), and Cco (control receiving corn oil) groups. (#)
indicates the comparison with the Cis (cisplatin-treated) group,
(&) indicates the comparison with the Squa (squalene-treated)
group. For statistical significance, P ≤ 0.05.

ANOVA, there were significant treatment effects between
groups (F(4,14) = 12.340, P = 0.001). Quantification
indicated that administration of squalene alone (Sgua
group) (65.32%) or after cisplatin treatment (Cis/Squa
group) (165.74%) increased the level of phospho-Akt
compared to the control group (Cs grup) (P = 0.031 and
P < 0.001, respectively). Meanwhile, the level of phosphoAkt to total Akt in cisplatin and squalene cotreated mice
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(Cis/Squa) was also higher than that of both in cisplatin
treated mice (Cis) (148%) and control mice receiving corn
oil (Cco) (120%) (P < 0.001) (Figure 4b).
The levels of the ratio of phospho-mTOR to total mTOR
proteins were also investigated (Figure 4c). According to
the one-way ANOVA, there were also significant treatment
effects between groups in the ratio of phospho-mTOR to
the mTOR (F(4,14) = 14.684, P < 0.001). The expression

SAKUL et al. / Turk J Biol

Figure 4. Western blot data of kidney tissue. (a) shows total GSK-3β, (b) p-Akt/total Akt, (c) p-mTOR/total mTOR, and (d) Nrf2. (*)
indicates the comparison with the Cs (control-received saline) group, (#) indicates the comparison with the Cis (cisplatin-treated)
group, (&) indicates the comparison with the Squa (squalene-treated) group, and (+) indicates the comparison with the Cco (control
receiving corn oil) group, all data were normalized against β-actin. For statistical significance, P ≤ 0.05.

of phospho-mTOR significantly decreased in cisplatintreated mice (32.13%), squalene-treated mice (48.69%),
and control mice receiving corn oil (33.01%) (P = 0.002, P
< 0.001, and P = 0.002, respectively). The expression level
of phospho-mTOR significantly increased in cisplatin
and squalene co-treated mice compared to those of the
cisplatin-treated mice, squalene-treated mice, and control
mice receiving corn oil, by 30%–40% (P = 0.003, P < 0.001,
and P = 0.003, respectively).
When the expression level of Nrf2 was investigated
by Western blotting, we observed a significant betweengroups difference according to one-way ANOVA (F(4,14)
= 4.152, P = 0.031). It was shown that the expression of Nrf2
significantly decreased in cisplatin and squalene cotreated
mice (Cis/Squa) (27.2%) and mice receiving corn oil (Cco)
(25.2%) relative to the control mice receiving saline (Cs)
(P = 0.032 and P = 0.044, respectively) (Figure 4d). The
very similar trend was observed when the levels of Nrf2
in cisplatin and squalene cotreated mice (Cis/Squa) and
mice receiving corn oil (Cco) were compared with those of
the cisplatin-treated mice (Cis) (P = 0.033 and P = 0.045,
respectively) and squalene-treated mice (Squa) (P = 0.012
and P = 0.016, respectively).
3.4. Histopathological changes
Histopathologically, there were no abnormal findings
for the kidney of the control mice receiving saline (Cs),
mice receiving corn oil (Cco), and squalene-treated mice
(Squa) in the light microscopic examination (Figures

5a–5c). Degenerative changes were observed in the renal
glomeruli and tubules of cisplatin-treated mice (Cis).
Dilatation in the capillaries and urinary spaces were noted
and the shape of the flat epithelial cells of the parietal layer
of Bowman’s membrane was mostly cuboidal or round. In
the proximal tubules, vacuolization and degeneration in
the endothelial cell cytoplasm and loss in the microvillus
structure were recorded (Figure 5d). Treatment with
squalene ameliorated these changes as showing almost the
same light microscopic appearance with controls in the
tubules and glomeruli (Figure 5e). The graded histological
changes (Mesangial matrix expansion) for each group are
shown in Figure 5f. According to one-way ANOVA, there
was a significant difference in the histopathological damage
score (H) score among groups (F(4,30) = 165,4, P ≤ 0.001).
The H score of cisplatin-treated mice was significantly
higher than those of all the other groups (P ≤ 0.001).
However, squalene administration decreased this H score
significantly in the cisplatin and squalene cotreated mice
compared to cisplatin-treated mice (P ≤ 0.001).
4. Discussion
Cisplatin is a well-known anticancer drug and it is
especially effective in certain types of cancers, for example
bladder, ovarian, and testicular carcinomas (Dasari and
Tchounwou, 2014). The mechanism of action of cisplatin
is very much similar to those of the other anticancer
agents; it directly interferes with the DNA replication
machinery of the cell by making crosslinks. Through these
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Figure 5. PAS staining was applied for identifying the effects of cisplatin exposure on the expansion of mezengial matrix scoring in
kidney tissues of the rats. Matrix expansion (shown with *) and proximal and distal tubul damages (shown with à) were detectable
in cisplatin groups (d). Treatment with squalene groups (e) resulted in almost normal tubules (shown with &) and matrix expansion
(shown with *) less than cisplatin group. In control (Cs) group (a), corn oil (Cco) (b), and squalene group (c) histological structure
were normal. Magnification, a–e: 40×. (f) Mesangial matrix expansion % tissue in the kidney glomeruli. (*) indicates the comparison
with the Cs (control receiving saline) group, (#) indicates the comparison with the cisplatin group, (&) indicates the comparison with
the squalene group, and (+) indicates the comparison with the Cco (control receiving corn oil) group, all data were normalized against
β-actin. For statistical significance, P ≤ 0.05.

crosslinks, cisplatin inhibits the cell to enter into mitotic
cycle, thereby cell proliferation is halted, and the apoptotic
program is activated. Although cisplatin’s therapeutic
effect significantly increases at high doses, its clinical use
is limited due to serious side effects such as nephrotoxicity
because kidneys are one of the main sites where toxins are
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concentrated in body due to high blood flow. Nephrotoxic
effect of cisplatin can reduce glomerular filtration rate
and cause serum electrolyte disturbances and permanent
kidney failure. Its toxic effects depend largely on oxidative
stress induction, and the prophylactic use of antioxidants
could sometimes help to decrease toxicity. Therefore, our

SAKUL et al. / Turk J Biol
study indicated that the nephrotoxic effects of cisplatin
could be attenuated by the use squalene with its antioxidant
and prosurvival effects.
First, our results clearly indicated that cisplatin
administration boosted the oxidative stress and application
of squalene reduced this oxidative stress. This is consistent
with the literature of cisplatin toxicity (Verma et al.,
2016) and the OSI data would provide a support for the
use of squalene as an antioxidant in chemotherapeutic
applications of cisplatin. Previously, it was suggested that
squalene exerts its anticarcinogenic activity by acting
as an antioxidant to enhance cellular antioxidant status
(Hashim et al., 2005; Smith, 2010). In addition, squalene
inhibits oxidative stress by reducing levels of reactive
oxygen species to protect against oxidative DNA damage
in human breast cancer (Warleta et al., 2010). Although
cisplatin exerted a definite oxidative stress on the kidneys
in our experimental model, renal tissue did not exhibit
any statistically significant change in the inflammatory
markers except IFN-γ. Based on these findings, it could
be considered that the inflammation-related toxic
effect of cisplatin on kidneys occurs through IFN-γ, as
previously observed in the study by Kimura et al. (2012).
The decrease in the IFN-γ level by the administration of
squalene after cisplatin treatment showed that squalene
may take its antioxidative or antiinflammatory effect
through inhibiting the IFN-γ expression in the kidney
cells. Therefore, these results clearly showed that cisplatin
treatment greatly induced the levels of OSI and IFN-γ in
our experimental animals and squalene administration
ameliorated the oxidative stress and inflammation.
It is well known that Nrf2 is a transcription factor,
and its expression is induced when cellular damage
occurs via oxidative stress, to regulate the adaptive
response to oxidants and electrophiles (Ma, 2013).
When a chemopreventive agent is given to the organism,
pharmacological boosting of the Nrf2 activity occurs to
protect the organism from oxidative damage that may
occur due to toxic metabolites or diseases such as cancer,
mitochondrial damage, or ethanol-induced lesions
(Talalay et al., 2003; Dong et al., 2008; He and Ma, 2012).
However, in our experimental model, Nrf2 expression
significantly decreased in cisplatin and squalene cotreated
mice relative to both control (Cs) and cisplatin-treated
mice. In a previous study, investigators also found that
dietary squalene supplementation did not change the
expression of Nrf2 protein in DSS-induced acute colitis
(Sánchez-Fidalgo et al., 2015).
Using the Western blot, we also investigated the
activation of AKT to observe the effect of squalene
administration on cell survival after cisplatin treatment
(Fu et al., 2016). In our study, a significant increase in
the phosphorylated AKT was observed in the squalene
treatment suggesting the cell survival enhancing effect of

squalene. This effect was more efficient where there was a
damaging factor such as cisplatin treatment, in our case. In
addition, the detrimental effect of cisplatin was especially
observed in the phosphorylation of mTOR protein.
Cisplatin induced inactivation of mTOR also observed
in the previous studies (Liu et al., 2018). It is generally
known that phosphorylated (activated) mTOR in the
complex of mTORC2 phosphorylates and activates AKT.
Similarly, the administration of squalene ameliorates the
effect of cisplatin on the phosphorylation of mTOR in the
kidney cells suggesting the action mechanism of squalene
through AKT/mTOR signaling pathway. Interestingly, it
is noted that squalene at very high doses (1%) exerts the
chemopreventive effect due to the HMG-CoA reductase
inhibition (Rao et al., 1998). As it was known, HMG-CoA
reductase inhibition attenuates AKT/mTOR signaling
and induces autophagy. In a previous in vitro study, it
was observed that using statins which are inhibitors of
HMG-CoA reductase impairs the phosphorylation of
AKT by activating mTOR and inhibiting forkhead box O
(FoxO) transcription factors (Bonifacio et al., 2015). In
addition, inhibition of HMG-CoA reductase inhibits lipidanchoring of the small G protein Rac1 to perturb mTOR
signaling which has been identified as a key modulator
of autophagy for more than a decade (Wei et al., 2013;
Paquette et al., 2018). However, the dosage of squalene that
we used increased the phosphorylation of AKT and mTOR
to behave as a prosurvival molecule.
On the other hand, a significant increase in total
GSK-3β was observed in cisplatin and squalene cotreated
mice. The data about GSK-3β may be interpreted with the
AKT data, because it is known that activation of AKT by
phosphorylation, which is one of the main prosurvival
proteins in the cell, inhibits GSK-3β phosphorylation
and stimulation suggesting an increase in the total
GSK-3β expression without affecting the expression of
phosphorylated GSK-3β (Hermida et al., 2017). These
findings indicate that inactive GSK-3β could not stimulate
apoptosis in kidneys; therefore, squalene can promote
the survival of renal cells which may protect the cells
from cisplatin’s toxic effects. In addition, the same effect
was observed in the corn oil group suggesting that the
increase in the expression of GSK-3β in the cisplatin and
squalene cotreated mice was independent from the effects
of squalene per se.
The molecular and cellular mechanisms of cisplatininduced renal cell death have been studied over the
past 10 years. Among these mechanisms, inflammation
occurring due to injury of renal epithelial cells had gained
importance because of its capacity to amplify kidney injury
and dysfunction in vivo (Arany and Safirstein, 2003; Sastry
and Kellie, 2005). A recent report indicated that cisplatin
therapy leads to the dilatation, vacuolization, and loss of
tubular epithelial cells; and glomerular degeneration and
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edema in the kidney tissues, as seen in our study (Eren et al.,
2018). The previous findings and our results also confirmed
that cisplatin produces high H score in the kidney (Ozkok
and Edelstein, 2014; Eren et al., 2018; Soyman et al., 2018;).
In the literature, these histopathological findings point
out the nephrotoxicity (Yao et al., 2007). In the current
study, squalene ameliorated nephrotoxicity occurring
due to cisplatin toxicity in mouse kidney, as evidenced by
lower H score. Treatment with squalene resulted in almost
normal tubules and glomeruli in the light microscopic
examination. The cause of nephrotoxicity is thought
that cisplatin accumulates in the proximal tubular inner
medulla and outer cortices of kidney after quick filtration
through the glomerular basal membrane and it results in
tubular cell death (Kulmann et al., 1997). The underlying
mechanisms of tubular cell death due to cisplatin treatment
includes oxidative stress, DNA adducts, inflammation,
mitochondrial dysfunction, apoptosis, and direct
cytotoxicity (Yao et al., 2007). However, several studies
showed the protective effects of antioxidative molecules
against cisplatin-induced damages (Eren et al., 2018;
Haghi-Aminjan et al., 2018; Soyman et al., 2018). Therefore,
we may suggest that squalene treatment ameliorated the

cisplatin-induced histopathological damages in the kidney
tissue by regulating the balance of the redox system due to
its antioxidative effect (Ondrejková et al., 2017).
In conclusion, our study results are the first to
indicate that squalene offers a protective effect against
cisplatin-induced nephrotoxicity in mice, by attenuating
the oxidative stress. Squalene activates the AKT/
mTOR signaling pathway and reduces histopathological
alterations in cisplatin-induced kidney damage. Therefore,
squalene administration may be a promising approach in
protecting kidney tissue from the detrimental effects of
cisplatin due to its antioxidative effect.
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